nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—Paraesthesia—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Isradipine—Arthralgia—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Isradipine—Chest pain—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Isradipine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Isradipine—Anxiety—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Isradipine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Isradipine—Dyspnoea—Leflunomide—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Isradipine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Isradipine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Isradipine—Discomfort—Lisinopril—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Isradipine—Lethargy—Methotrexate—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Isradipine—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Isradipine—Dyspepsia—Leflunomide—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Isradipine—Vomiting—Mometasone—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Isradipine—Dry mouth—Lisinopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Isradipine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Isradipine—Rash—Mometasone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Isradipine—Asthenia—Captopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Isradipine—Dermatitis—Mometasone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Isradipine—Decreased appetite—Leflunomide—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Isradipine—Headache—Mometasone—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Isradipine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Isradipine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Isradipine—Fatigue—Leflunomide—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Isradipine—Oedema—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Isradipine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Isradipine—Pruritus—Captopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Isradipine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Isradipine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Isradipine—Constipation—Leflunomide—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Isradipine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Isradipine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Isradipine—Somnolence—Mycophenolic acid—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Isradipine—Shock—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Isradipine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Isradipine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Isradipine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Isradipine—Tachycardia—Lisinopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Isradipine—Skin disorder—Lisinopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Isradipine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Isradipine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Isradipine—Diarrhoea—Captopril—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Isradipine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Isradipine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Isradipine—Erectile dysfunction—Prednisone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Isradipine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Isradipine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Isradipine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Isradipine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Isradipine—Nausea—Mometasone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Isradipine—Weight increased—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Isradipine—Constipation—Mycophenolic acid—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Isradipine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Isradipine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Isradipine—Cough—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Isradipine—Hypotension—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Isradipine—Dizziness—Captopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Isradipine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Isradipine—Depression—Prednisone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Isradipine—Urticaria—Leflunomide—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Isradipine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Isradipine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Isradipine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Isradipine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Isradipine—Myocardial infarction—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Isradipine—Breast disorder—Methotrexate—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Isradipine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Isradipine—Insomnia—Lisinopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Isradipine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Isradipine—Paraesthesia—Lisinopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Isradipine—Vomiting—Captopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Isradipine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Isradipine—Dyspnoea—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Isradipine—Rash—Captopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Isradipine—Dermatitis—Captopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Isradipine—Somnolence—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Isradipine—Headache—Captopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Isradipine—Dyspepsia—Lisinopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Isradipine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Isradipine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Isradipine—Decreased appetite—Lisinopril—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Isradipine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Isradipine—Fatigue—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Isradipine—Shock—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Isradipine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Isradipine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Isradipine—Constipation—Lisinopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Isradipine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Isradipine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Isradipine—Bradycardia—Prednisone—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Isradipine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Isradipine—Diarrhoea—Azathioprine—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Isradipine—Nausea—Captopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Isradipine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Isradipine—Asthenia—Leflunomide—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Isradipine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Isradipine—Pruritus—Leflunomide—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Isradipine—Connective tissue disorder—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Isradipine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Isradipine—Dizziness—Azathioprine—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Isradipine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Isradipine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Isradipine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Isradipine—Diarrhoea—Leflunomide—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Isradipine—Urticaria—Lisinopril—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Isradipine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Isradipine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Isradipine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Isradipine—Vomiting—Azathioprine—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Isradipine—Eye disorder—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Isradipine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Isradipine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Isradipine—Drowsiness—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Isradipine—Rash—Azathioprine—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Isradipine—Dermatitis—Azathioprine—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Isradipine—Depression—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Isradipine—Flushing—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Isradipine—Headache—Azathioprine—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Isradipine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Isradipine—Dizziness—Leflunomide—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Isradipine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.001	0.001	CcSEcCtD
Isradipine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000998	0.000998	CcSEcCtD
Isradipine—Angiopathy—Prednisone—systemic scleroderma	0.000996	0.000996	CcSEcCtD
Isradipine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000994	0.000994	CcSEcCtD
Isradipine—Immune system disorder—Prednisone—systemic scleroderma	0.000992	0.000992	CcSEcCtD
Isradipine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000984	0.000984	CcSEcCtD
Isradipine—Vomiting—Leflunomide—systemic scleroderma	0.000972	0.000972	CcSEcCtD
Isradipine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Isradipine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000965	0.000965	CcSEcCtD
Isradipine—Rash—Leflunomide—systemic scleroderma	0.000964	0.000964	CcSEcCtD
Isradipine—Dermatitis—Leflunomide—systemic scleroderma	0.000963	0.000963	CcSEcCtD
Isradipine—Mental disorder—Prednisone—systemic scleroderma	0.000962	0.000962	CcSEcCtD
Isradipine—Nausea—Azathioprine—systemic scleroderma	0.000962	0.000962	CcSEcCtD
Isradipine—Headache—Leflunomide—systemic scleroderma	0.000958	0.000958	CcSEcCtD
Isradipine—Malnutrition—Prednisone—systemic scleroderma	0.000956	0.000956	CcSEcCtD
Isradipine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000949	0.000949	CcSEcCtD
Isradipine—Asthenia—Lisinopril—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Isradipine—Pruritus—Lisinopril—systemic scleroderma	0.00093	0.00093	CcSEcCtD
Isradipine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000927	0.000927	CcSEcCtD
Isradipine—Rash—Mycophenolic acid—systemic scleroderma	0.00092	0.00092	CcSEcCtD
Isradipine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000919	0.000919	CcSEcCtD
Isradipine—Hepatitis—Methotrexate—systemic scleroderma	0.000918	0.000918	CcSEcCtD
Isradipine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000914	0.000914	CcSEcCtD
Isradipine—Headache—Mycophenolic acid—systemic scleroderma	0.000914	0.000914	CcSEcCtD
Isradipine—Nausea—Leflunomide—systemic scleroderma	0.000908	0.000908	CcSEcCtD
Isradipine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000906	0.000906	CcSEcCtD
Isradipine—Vision blurred—Prednisone—systemic scleroderma	0.000901	0.000901	CcSEcCtD
Isradipine—Urethral disorder—Methotrexate—systemic scleroderma	0.0009	0.0009	CcSEcCtD
Isradipine—Diarrhoea—Lisinopril—systemic scleroderma	0.000899	0.000899	CcSEcCtD
Isradipine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000887	0.000887	CcSEcCtD
Isradipine—Visual impairment—Methotrexate—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Isradipine—Anaemia—Prednisone—systemic scleroderma	0.000884	0.000884	CcSEcCtD
Isradipine—Angioedema—Prednisone—systemic scleroderma	0.000874	0.000874	CcSEcCtD
Isradipine—Dizziness—Lisinopril—systemic scleroderma	0.000869	0.000869	CcSEcCtD
Isradipine—Nausea—Mycophenolic acid—systemic scleroderma	0.000866	0.000866	CcSEcCtD
Isradipine—Malaise—Prednisone—systemic scleroderma	0.000862	0.000862	CcSEcCtD
Isradipine—Eye disorder—Methotrexate—systemic scleroderma	0.000858	0.000858	CcSEcCtD
Isradipine—Syncope—Prednisone—systemic scleroderma	0.000857	0.000857	CcSEcCtD
Isradipine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000852	0.000852	CcSEcCtD
Isradipine—Loss of consciousness—Prednisone—systemic scleroderma	0.00084	0.00084	CcSEcCtD
Isradipine—Vomiting—Lisinopril—systemic scleroderma	0.000835	0.000835	CcSEcCtD
Isradipine—Angiopathy—Methotrexate—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Isradipine—Immune system disorder—Methotrexate—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Isradipine—Rash—Lisinopril—systemic scleroderma	0.000828	0.000828	CcSEcCtD
Isradipine—Dermatitis—Lisinopril—systemic scleroderma	0.000828	0.000828	CcSEcCtD
Isradipine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000827	0.000827	CcSEcCtD
Isradipine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000826	0.000826	CcSEcCtD
Isradipine—Headache—Lisinopril—systemic scleroderma	0.000823	0.000823	CcSEcCtD
Isradipine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Isradipine—Arthralgia—Prednisone—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Isradipine—Anxiety—Prednisone—systemic scleroderma	0.000811	0.000811	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Isradipine—Discomfort—Prednisone—systemic scleroderma	0.000804	0.000804	CcSEcCtD
Isradipine—Mental disorder—Methotrexate—systemic scleroderma	0.000804	0.000804	CcSEcCtD
Isradipine—Malnutrition—Methotrexate—systemic scleroderma	0.000799	0.000799	CcSEcCtD
Isradipine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Isradipine—Nausea—Lisinopril—systemic scleroderma	0.00078	0.00078	CcSEcCtD
Isradipine—Oedema—Prednisone—systemic scleroderma	0.00078	0.00078	CcSEcCtD
Isradipine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00078	0.00078	CcSEcCtD
Isradipine—Back pain—Methotrexate—systemic scleroderma	0.000773	0.000773	CcSEcCtD
Isradipine—Shock—Prednisone—systemic scleroderma	0.000768	0.000768	CcSEcCtD
Isradipine—Nervous system disorder—Prednisone—systemic scleroderma	0.000765	0.000765	CcSEcCtD
Isradipine—Tachycardia—Prednisone—systemic scleroderma	0.000762	0.000762	CcSEcCtD
Isradipine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Isradipine—Skin disorder—Prednisone—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Isradipine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000754	0.000754	CcSEcCtD
Isradipine—Vision blurred—Methotrexate—systemic scleroderma	0.000753	0.000753	CcSEcCtD
Isradipine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000741	0.000741	CcSEcCtD
Isradipine—Anaemia—Methotrexate—systemic scleroderma	0.000739	0.000739	CcSEcCtD
Isradipine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000732	0.000732	CcSEcCtD
Isradipine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Isradipine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000725	0.000725	CcSEcCtD
Isradipine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Isradipine—Malaise—Methotrexate—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Isradipine—Leukopenia—Methotrexate—systemic scleroderma	0.000715	0.000715	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000711	0.000711	CcSEcCtD
Isradipine—Insomnia—Prednisone—systemic scleroderma	0.000706	0.000706	CcSEcCtD
Isradipine—Paraesthesia—Prednisone—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Isradipine—Cough—Methotrexate—systemic scleroderma	0.000697	0.000697	CcSEcCtD
Isradipine—Dyspepsia—Prednisone—systemic scleroderma	0.000687	0.000687	CcSEcCtD
Isradipine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000684	0.000684	CcSEcCtD
Isradipine—Arthralgia—Methotrexate—systemic scleroderma	0.00068	0.00068	CcSEcCtD
Isradipine—Chest pain—Methotrexate—systemic scleroderma	0.00068	0.00068	CcSEcCtD
Isradipine—Decreased appetite—Prednisone—systemic scleroderma	0.000678	0.000678	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000676	0.000676	CcSEcCtD
Isradipine—Fatigue—Prednisone—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Isradipine—Discomfort—Methotrexate—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Isradipine—Constipation—Prednisone—systemic scleroderma	0.000667	0.000667	CcSEcCtD
Isradipine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000652	0.000652	CcSEcCtD
Isradipine—Feeling abnormal—Prednisone—systemic scleroderma	0.000643	0.000643	CcSEcCtD
Isradipine—Nervous system disorder—Methotrexate—systemic scleroderma	0.00064	0.00064	CcSEcCtD
Isradipine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000638	0.000638	CcSEcCtD
Isradipine—Skin disorder—Methotrexate—systemic scleroderma	0.000633	0.000633	CcSEcCtD
Isradipine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00063	0.00063	CcSEcCtD
Isradipine—Urticaria—Prednisone—systemic scleroderma	0.00062	0.00062	CcSEcCtD
Isradipine—Hypotension—Methotrexate—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000594	0.000594	CcSEcCtD
Isradipine—Insomnia—Methotrexate—systemic scleroderma	0.00059	0.00059	CcSEcCtD
Isradipine—Paraesthesia—Methotrexate—systemic scleroderma	0.000586	0.000586	CcSEcCtD
Isradipine—Dyspnoea—Methotrexate—systemic scleroderma	0.000581	0.000581	CcSEcCtD
Isradipine—Somnolence—Methotrexate—systemic scleroderma	0.00058	0.00058	CcSEcCtD
Isradipine—Dyspepsia—Methotrexate—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Isradipine—Decreased appetite—Methotrexate—systemic scleroderma	0.000567	0.000567	CcSEcCtD
Isradipine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000563	0.000563	CcSEcCtD
Isradipine—Fatigue—Methotrexate—systemic scleroderma	0.000562	0.000562	CcSEcCtD
Isradipine—Asthenia—Prednisone—systemic scleroderma	0.00056	0.00056	CcSEcCtD
Isradipine—Pruritus—Prednisone—systemic scleroderma	0.000552	0.000552	CcSEcCtD
Isradipine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Isradipine—Diarrhoea—Prednisone—systemic scleroderma	0.000534	0.000534	CcSEcCtD
Isradipine—Urticaria—Methotrexate—systemic scleroderma	0.000518	0.000518	CcSEcCtD
Isradipine—Dizziness—Prednisone—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Isradipine—Vomiting—Prednisone—systemic scleroderma	0.000496	0.000496	CcSEcCtD
Isradipine—Rash—Prednisone—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Isradipine—Dermatitis—Prednisone—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Isradipine—Headache—Prednisone—systemic scleroderma	0.000489	0.000489	CcSEcCtD
Isradipine—Asthenia—Methotrexate—systemic scleroderma	0.000468	0.000468	CcSEcCtD
Isradipine—Nausea—Prednisone—systemic scleroderma	0.000463	0.000463	CcSEcCtD
Isradipine—Pruritus—Methotrexate—systemic scleroderma	0.000461	0.000461	CcSEcCtD
Isradipine—Diarrhoea—Methotrexate—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Isradipine—Dizziness—Methotrexate—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Isradipine—Vomiting—Methotrexate—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Isradipine—Rash—Methotrexate—systemic scleroderma	0.000411	0.000411	CcSEcCtD
Isradipine—Dermatitis—Methotrexate—systemic scleroderma	0.000411	0.000411	CcSEcCtD
Isradipine—Headache—Methotrexate—systemic scleroderma	0.000409	0.000409	CcSEcCtD
Isradipine—Nausea—Methotrexate—systemic scleroderma	0.000387	0.000387	CcSEcCtD
